Table 1.
Descriptive characteristics in maximal available sample (n = 15 253)
| Outcomes, mean ± SD | Full sample | Females | Males |
|---|---|---|---|
| (n = 15 253) | (n = 8341; 54.7%) | (n = 6912; 45.3%) | |
| BMI (kg/m2) | 27.0 ± 4.9 | 26.7 ± 5.4 | 27.4 ± 4.3 |
| Waist circumference (cm) | 94.1 ± 13.9 | 89.2 ± 13.2 | 100.2 ± 12.1 |
| HDL cholesterol (mmol/L) | 1.57 ± 0.46 | 1.7 ± 0.5 | 1.4 ± 0.4 |
| HDL: total cholesterol ratio | 3.64 ± 1.23 | 3.3 ± 1.0 | 4.0 ± 1.3 |
| HbA1c (mmol/mol) | 38.0 ± 8.7 | 36.7 ± 7.3 | 39.4 ± 9.8 |
| Triglycerides (mmol/L) | 1.48 ± 1.04 | 1.3 ± 0.8 | 1.7 ± 1.2 |
| Movement behaviour compositiona (h/day; % of day) | |||
| Sleep | 7.7 (31.9%) | 7.9 (32.8%) | 7.4 (30.9%) |
| Sedentary behaviour | 10.4 (43.2%) | 9.9 (42.3%) | 10.9 (45.4%) |
| Standing | 3.1 (13.0%) | 3.3 (13.9%) | 2.9 (11.9%) |
| LIPA | 1.5 (6.4%) | 1.5 (6.3%) | 1.6 (6.5%) |
| MVPA | 1.3 (5.5%) | 1.4 (5.7%) | 1.3 (5.3%) |
| Main analyses covariates [mean ± SD or n (%)] | |||
| Age (years) | 53.7 ± 9.7 | 52.7 ± 9.1 | 55.1 ± 10.2 |
| Cohort | |||
| TMS | 7515 (49.3) | 3790 (45.4) | 3725 (53.9) |
| BCS70 | 5236 (34.3) | 2797 (33.5) | 2439 (35.3) |
| ALSWH | 941 (6.1) | 941 (11.3) | 0 (0) |
| DPhacto | 777 (5.1) | 359 (4.3) | 412 (6.0) |
| NES | 537 (3.5) | 244 (2.9) | 293 (4.2) |
| FIREA | 253 (1.7) | 210 (2.5) | 43 (0.6) |
| Smoking status | |||
| Non-smoker | 12 953 (85.4) | 7205 (86.8) | 5748 (83.7) |
| Current smoker | 2211 (14.6) | 1093 (13.2) | 1118 (16.3) |
| Alcohol consumption | |||
| Tertile 1 (low) | 4463 (33.8) | 3058 (42.6) | 1405 (23.3) |
| Tertile 2 | 4514 (34.2) | 2529 (35.2) | 1985 (32.9) |
| Tertile 3 (high) | 4231 (32.0) | 1591 (22.2) | 2640 (43.8) |
| Self-reported healthb | |||
| Excellent | 1849 (12.3) | 1102 (13.4) | 747 (11.0) |
| Very good | 4905 (32.7) | 2701 (32.9) | 2204 (32.4) |
| Good | 6329 (42.2) | 3337 (40.6) | 2992 (44.1) |
| Fair | 1634 (10.9) | 908 (11.1) | 726 (10.7) |
| Poor | 287 (1.9) | 164 (2.0) | 123 (1.8) |
| Medication (lipid-modifying, hypertensive, or glucose-lowering) | 4333 (29.9) | 1859 23.3) | 2474 (38.1) |
| History of CVD | 1486 (9.8) | 615 7.4) | 871 (12.7) |
| Supplementary analyses covariatesc [mean ± SD or n (%)] | |||
| Physical function (SF-36) | 87.2 ± 18.8 | 86.5 ± 18.9 | 88.0 ± 18.6 |
| Occupational class | |||
| Not working | 3850 (29.3) | 2014 (28.1) | 1836 (30.6) |
| Low | 2152 (16.4) | 1023 (14.3) | 1129 (18.8) |
| Intermediate | 3645 (27.7) | 1927 (26.9) | 1718 (28.7) |
| High | 3502 (26.6) | 2192 (30.6) | 1310 (21.9) |
| Education | |||
| None or less than high school | 1666 (11.9) | 764 (9.9) | 902 (14.2) |
| High school (∼16 years) | 3908 (27.8) | 2209 (28.7) | 1699 (26.7) |
| Further education (∼16–18 years) | 5399 (38.4) | 2955 (38.4) | 2444 (38.4) |
| University degree or higher | 3080 (21.9) | 1760 (22.9) | 1320 (20.7) |
ALSWH, Australian Longitudinal Study of Women’s Health; BMI, body mass index; BCS70, 1970 British Cohort Study; CVD, cardiovascular disease; DPhacto, Danish PHysical ACTivity cohort with Objective measurements; FIREA, Finnish Retirement and Aging Study; HDL, high density lipoprotein; LIPA, light-intensity physical activity; MVPA, moderate-vigorous intensity physical activity; NES, Nijmegen Exercise Study; SD, standard deviation; SF-36, Short-Form 36; TMS, The Maastricht Study.
aRe-scaled to a 24 h day to create the composition.
bResponse terminology differs slightly by cohort, given translation of original question (see Supplementary data online, Table S1).
cCovariates available in restricted cohorts only (see Supplementary data online, Table S1).